<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: The aim of the present work was to study the diagnostic value of the measurement of total serum <z:chebi fb="1" ids="3098">bile acids</z:chebi> in patients with <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> as compared to the fasting test </plain></SENT>
<SENT sid="1" pm="."><plain>PATIENTS AND METHODS: We have studied 17 patients, 12 males and 5 females, between the ages of 7 and 15 years </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients showed a slight <z:hpo ids='HP_0008282'>unconjugated hyperbilirubinemia</z:hpo> (1.4 +/- 0.5 mg/dl) in the presence of repeated <z:mpath ids='MPATH_458'>normal</z:mpath> liver function test, including the total serum <z:chebi fb="1" ids="3098">bile acids</z:chebi> (7.47 +/- 2.3 mumol/l), and showed no evidence of <z:mp ids='MP_0010163'>hemolysis</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>A modified fasting test was performed in <z:hpo ids='HP_0000001'>all</z:hpo> of the patients </plain></SENT>
<SENT sid="4" pm="."><plain>Serum <z:chebi fb="0" ids="3098">bile acid</z:chebi> levels (Merckotest, Merck Labs) and the biochemical parameters of liver function were determined before and after the fasting test </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Our results show that to confirm the diagnosis of <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e>, the fasting test could be avoided in patients with increased unconjugated <z:chebi fb="0" ids="16990">bilirubin</z:chebi> levels if the basal levels of total serum <z:chebi fb="1" ids="3098">bile acids</z:chebi> are <z:mpath ids='MPATH_458'>normal</z:mpath> </plain></SENT>
</text></document>